SHYCOCAN PERFORMANCE
99.994% ( >4log10 ) reduction in a standard MS2 Bacteriophage decontamination assay

99.963% reduction of an EPA-standard SARS-CoV-2 surrogate, in BSL-2 facilities.

Elimination of expected Influenza B viral loads, in BSL-2 facilities. 

SARS-CoV-2 assays in enhanced BSL-2 and BSL-3 facilities are currently underway 

Can be run 24/7 and operates on standard 110/240v wall outlet

Plug and play device with no setup required except for mounting on side wall, pedestal or table-top